Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- B group Purinostat MesylatePhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
- B013Phase 21 trial
Shanghai Jiaolian Drug Research and Development Co., Ltd · Platinum-resistant Recurrent Ovarian Cancer
- B2065Phase 21 trial
Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke
- B244Phase 21 trial
AOBiome LLC · Acne Vulgaris
- BalstililmabPhase 21 trial
Nelum Corp · Untreated, Advanced Pancreatic Cancer
- BAT1006Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAT8008Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAT8010Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAY 3401016Phase 21 trial
Bayer · Alport Syndrome
- BAY 3670549Phase 21 trial
Bayer · Atrial Fibrillation
- BAY 3713372Phase 21 trial
Bayer · MTAP-deleted Solid Tumors
- BAY2599023DTX201Phase 21 trial
Bayer · Hemophilia A
- BAY3018250Phase 21 trial
Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis
- BAY3283142Phase 21 trial
Bayer · Chronic Kidney Disease
- BB-031DTRI-031Phase 21 trial
Basking Biosciences, Inc. · Acute Ischemic Stroke
- BB-101Phase 21 trial
Blue Blood Biotech Corp. · Diabetic Foot Ulcer
- BB-1701Phase 21 trial
Eisai · Breast Cancer
- BB102Phase 21 trial
Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)
- BBI-001Phase 21 trial
Bond Biosciences · Hereditary Hemochromatosis
- BBT-207Phase 21 trial
Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer
- BBT-877Phase 21 trial
Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis
- BBT001Phase 21 trial
Bambusa Therapeutics · Chronic Spontaneous Urticaria
- BBT002Phase 21 trial
Bambusa Therapeutics · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- BC006Phase 21 trial
Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)
- BC3195Phase 21 trial
Biocity Biopharmaceutics Co., Ltd. · Locally Advanced or Metastatic Solid Tumors
- BCB-276Phase 21 trial
BrainChild Bio, Inc · Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor
- BCD-236Phase 21 trial
Biocad · Triple Negative Breast Cancer
- BDC-4182Phase 21 trial
Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
- BEAM-101Phase 21 trial
Beam Therapeutics Inc. · Sickle Cell Disease
- BEAM-201Phase 21 trial
Beam Therapeutics Inc. · Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
- BEAM-302Phase 21 trial
Beam Therapeutics Inc. · Alpha 1-Antitrypsin Deficiency
- BEBT-701Phase 21 trial
BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
- BemnifosbuvirAT-527Phase 21 trial
Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C
- BerubicinPhase 21 trial
CNS Pharmaceuticals, Inc. · Glioblastoma Multiforme, Adult
- BEY2153Phase 21 trial
BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease
- BFB-101AAV9-CBh-AP4B1Phase 21 trial
BlackfinBio Ltd · HSP, Hereditary Spastic Paraplegia, Hereditary Spastic Paraparesis
- BG1805Phase 21 trial
Guangzhou Bio-gene Technology Co., Ltd · Leukemia, Myeloid, Acute
- BGC101autologous EnEPC preparationPhase 21 trial
Biogen · Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
- BGM1812plcaeboPhase 21 trial
BrightGene Bio-Medical Technology Co., Ltd. · Overweight or Obese Participants Without Diabetes
- BGP-014Phase 21 trial
BioGaia Pharma AB · Ulcerative Colitis
- BH-30643Phase 21 trial
BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)
- BHB810Phase 21 trial
BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer
- BHV-1510PBI-410, GQ1010Phase 21 trial
Biohaven Therapeutics Ltd. · Solid Tumor
- BHV-2100Phase 21 trial
Biohaven Therapeutics Ltd. · Migraine
- BI 1584862Phase 21 trial
Boehringer Ingelheim · Geographic Atrophy
- BI 1815368Phase 21 trial
Boehringer Ingelheim · Macular Edema
- BI 1819479Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 3000202Phase 21 trial
Boehringer Ingelheim · Systemic Lupus Erythematosus
- BI 3032950Phase 21 trial
Boehringer Ingelheim · Ulcerative Colitis
- BI 3034701Phase 21 trial
Boehringer Ingelheim · Obesity, Overweight
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.